| Results from METIS (EF-25), an international, multicenter phase III randomized study evaluating the efficacy and safety of tumor treating fields (TTFields) therapy in NSCLC … MP Mehta, V Gondi, MS Ahluwalia, D Roberge, R Ilic, TTW Sio, ... Journal of Clinical Oncology 42 (16_suppl), 2008-2008, 2024 | | 2024 |
| Concurrent lapatinib with brain radiation therapy in patients with HER2+ breast cancer with brain metastases: NRG Oncology–KROG/RTOG 1119 phase 2 randomized trial IA Kim, KA Winter, PW Sperduto, F Jennifer, DM Peereboom, T Ogunleye, ... International Journal of Radiation Oncology* Biology* Physics 118 (5), 1391-1401, 2024 | 4 | 2024 |
| Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors’ response in non-small cell lung cancer: a multicenter cohort study M Tonneau, K Phan, VSK Manem, C Low-Kam, F Dutil, S Kazandjian, ... Frontiers in Oncology 13, 1196414, 2023 | 4 | 2023 |
| Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer E Auclin, J Benitez-Montanez, M Tagliamento, F Parisi, T Gorria, ... Lung Cancer 178, 116-122, 2023 | 11 | 2023 |
| 1298 A weakly supervised deep learning framework to predict KRAS-STK11 and KRAS-TP53 co-mutations in lung adenocarcinomas using H&E tissue sections D Jiménez-Sánchez, C De Andrea, Á López-Janeiro, MD Lozano, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| OA07. 06 Second line treatment outcomes after progression on immunotherapy plus chemotherapy (IO-CT) in advanced non-small cell lung cancer (aNSCLC) E Auclin, J Benitez-Montanez, T Gorria, R Garcia-Campelo, N Dempsey, ... Journal of Thoracic Oncology 17 (9), S22, 2022 | 4 | 2022 |
| Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label … BH Chua, EK Link, IH Kunkler, TJ Whelan, AH Westenberg, G Gruber, ... The Lancet 400 (10350), 431-440, 2022 | 54 | 2022 |
| Neuronal GPR81 regulates developmental brain angiogenesis and promotes brain recovery after a hypoxic ischemic insult P Chaudhari, A Madaan, JC Rivera, I Charfi, T Habelrih, X Hou, ... Journal of Cerebral Blood Flow & Metabolism 42 (7), 1294-1308, 2022 | 20 | 2022 |
| Predicted long‐term impact of COVID‐19 pandemic‐related care delays on cancer mortality in Canada T Malagón, JHE Yong, P Tope, WH Miller Jr, EL Franco, ... International journal of cancer 150 (8), 1244-1254, 2022 | 73 | 2022 |
| Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib S Owen, S Alken, J Alshami, MC Guiot, P Kavan, DA Reardon, T Muanza, ... OncoTargets and therapy, 367-380, 2022 | 2 | 2022 |
| Population-based analysis of non-operative management and treatment patterns in older women with estrogen receptor-positive breast cancer D Tejera, M Rana, M Basik, JF Boileau, R Margolese, I Prakash, ... Breast Cancer Research and Treatment 190, 491-501, 2021 | 3 | 2021 |
| 1357P A deep radiomics approach to assess PD-L1 expression and clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors … M Tonneau, K Phan, S Kazandjian, A Elkrief, J Panasci, C Richard, ... Annals of Oncology 32, S1029, 2021 | 1 | 2021 |
| Oncologic safety of sentinel lymph node biopsy alone after neoadjuvant chemotherapy for breast cancer SM Wong, M Basik, L Florianova, R Margolese, S Dumitra, T Muanza, ... Annals of Surgical Oncology 28, 2621-2629, 2021 | 49 | 2021 |
| CTNI-05. NRG ONCOLOGY/RTOG 1119: phase II randomized study of whole brain radiotherapy/stereotactic radiosurgery with concurrent lapatinib in patients with brain metastases … IA Kim, K Winter, P Sperduto, J De Los Santos, D Peereboom, T Ogunleye, ... Neuro-Oncology 22 (Suppl 2), ii42, 2020 | 4 | 2020 |
| NRG ONCOLOGY/RTOG 1119: Phase II randomized study of whole brain radiotherapy/stereotactic radiosurgery with concurrent lapatinib in patients with brain metastases from HER2 … IA Kim, J Moughan, PW Sperduto, JF De Los Santos, D Peereboom, ... International Journal of Radiation Oncology, Biology, Physics 108 (3), S174-S175, 2020 | 8* | 2020 |
| Breast cancer in women aged 80 years and older: Clinical characteristics and treatment patterns according to biologic subtype. SM Wong, JF Boileau, M Rana, T Muanza, RG Margolese, J Monette, ... Journal of Clinical Oncology 38 (15_suppl), e12594-e12594, 2020 | | 2020 |
| Locoregional recurrence following pathologic complete response in patients with T1-3 N0 breast cancer treated with neoadjuvant chemotherapy, breast conserving surgery and whole … E Parvez, T Muanza Journal of Clinical Oncology 38 (15_suppl), e12625-e12625, 2020 | | 2020 |
| Oncologic Safety of Sentinel Lymph Node Biopsy Alone Following Neoadjuvant Chemotherapy for Breast Cancer SM Wong, M Basik, S Dumitra, RG Margolese, T Muanza, A Carbonneau, ... ANNALS OF SURGICAL ONCOLOGY 27 (SUPPL 1), S69-S69, 2020 | | 2020 |
| External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative … TJ Whelan, JA Julian, TS Berrang, DH Kim, I Germain, AM Nichol, M Akra, ... The Lancet 394 (10215), 2165-2172, 2019 | 357 | 2019 |
| Combining prostate cancer radiotherapy with therapies targeting the androgen receptor axis M Ghashghaei, M Kucharczyk, S Elakshar, T Muanza, T Niazi Current oncology 26 (5), 640-650, 2019 | 9 | 2019 |
